Mangoceuticals (MGRX) Return on Capital Employed (2023 - 2026)
Mangoceuticals (MGRX) posted Return on Capital Employed of 112.21% for Q1 2026, up 2.55% sequentially from 115.15% in Q4 2025, and down 5253.0% YoY from 2.18% in Q1 2025.
Mangoceuticals (MGRX) Return on Capital Employed (2023 - 2026) Analysis & Trends
Mangoceuticals has reported Return on Capital Employed for 4 years, with the latest figure at 112.21% in Q1 2026.
- Quarterly Return on Capital Employed fell 5253.0% year-over-year to 112.21% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 112.21% (down 5253.0% YoY) and the FY2025 annual result came in at 121.52%, down 402.0% from the prior year.
- Return on Capital Employed advanced to 112.21% in Q1 2026 per MGRX's latest filing, from 115.15% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 1683.96% in Q1 2024 and troughed at 828.98% in Q4 2023.
- A 4-year average of 13.12% and a median of 87.02% in 2025 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed soared 77061 bps in 2024, then slumped 174364 bps in 2025.
- Over 4 years, Return on Capital Employed stood at 828.98% in 2023, then jumped by 93 bps to 58.38% in 2024, then tumbled by 97 bps to 115.15% in 2025, then rose by 3 bps to 112.21% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 112.21%, 115.15%, and 106.61% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 13.00% |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 9.85% |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 10.67% |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | -9.77% |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 31.58% |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | -8.46% |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 4.91% |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 20.35% |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | -20.94% |
| 10 | Mangoceuticals | 9.55 Mn | 9.30 Mn | 44,215.00 | -93.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -93.47% |
| Mar 31, 2026 | -112.21% |
| Dec 31, 2025 | -115.15% |
| Sep 30, 2025 | -106.61% |
| Jun 30, 2025 | -67.42% |
| Mar 31, 2025 | -59.68% |
| Dec 31, 2024 | -58.38% |
| Sep 30, 2024 | -65.05% |
| Jun 30, 2024 | -139.31% |
| Mar 31, 2024 | 1,683.96% |
| Dec 31, 2023 | -828.98% |